Combination treatment for nicotine dependence: state of the science
- PMID: 16282086
- PMCID: PMC2868059
- DOI: 10.1080/10826080500294817
Combination treatment for nicotine dependence: state of the science
Abstract
Both nicotine replacement and sustained-release buproprion double the odds of achieving short- and moderate-term abstinence from nicotine. However, questions remain about the efficacy of combining pharmacotherapies. Our purposes were to review the evidence for (1) combined pharmacotherapy and (2) multimodal treatment combining pharmacotherapy and behavioral treatment and to recommend combinations of treatments to reduce nicotine dependence. Combining first-line pharmacotherapies with each other or with investigational drugs shows little benefit. In contrast, trials combining specific behavioral treatments with first-line pharmacotherapies show enhanced smoking cessation rates, but benefits are not seen in all populations. We recommend future directions for research, including better specification of behavioral components and further examination of the length and timing of treatment.
Comment in
-
Introduction to special issue "addiction pharmacotherapy and special populations".Subst Use Misuse. 2005;40(13-14):1895-7. doi: 10.1080/10826080500303675. Subst Use Misuse. 2005. PMID: 16282084 No abstract available.
References
-
- Ahmadi J, Ashkani H, Ahmadi M, Ahmadi N. Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone. Journal of Substance Abuse Treatment. 2003;24:251–255. - PubMed
-
- Balfour DJ. The pharmacology underlying pharmacotherapy for tobacco dependence: A focus on bupropion. International Journal of Clinical Practice. 2001;55:53–57. - PubMed
-
- Benowitz NL. The biology of nicotine dependence; from the 1988 Surgeon General’s Report to the present and into the future. Nicotine & Tobacco Research. 1999;1:S159–S163. - PubMed
-
- Biberman R, Neumann R, Katzir I, Gerber Y. A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation. Addiction. 2003;98:1403–1407. - PubMed
-
- Blondal T, Gudmundsson LJ, Tomasson K, Jonsdottir D, Hilmarsdottir H, Kristjansson F, Nilsson F, Bjornsdottir US. The effects of fluoxetine combined with nicotine inhalers in smoking cessation—a randomized trial. Addiction. 1999;94:1007–1015. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical